AMRN Projected Dividend Yield
ADR (Sponsored) New/Amarin Corp Plc ( NASDAQ : AMRN )Amarin Corporation PLC is a pharmaceutical company. Co. is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. Co. operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. 21 YEAR PERFORMANCE RESULTS |
AMRN Dividend History Detail AMRN Dividend News AMRN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |